化学
生物高聚物
溶解度
生物相容性
环糊精
药品
药物输送
组合化学
纳米技术
药理学
材料科学
聚合物
有机化学
医学
作者
Chandrakantsing V. Pardeshi,Rucha V Kothawade,Ashwini R Markad,Sagar R. Pardeshi,Abhijeet D. Kulkarni,Prashant Chaudhari,Marcela R. Longhi,Namdev Dhas,Jitendra Naik,Sanjay J. Surana,Mónica Cristina García
标识
DOI:10.1016/j.carbpol.2022.120347
摘要
Sulfobutylether β-cyclodextrin (SBE-β-CD) is a polyanionic cyclic oligosaccharide that contains glucopyranose units forming a torus ring-like structure. SBE-β-CD is gifted with many favorable properties viz. relatively high solubility (>50 folds compared to β-CD), improved stability, and biocompatibility that praised SBE-β-CD as a smart polymer for drug delivery applications. Commercially, SBE-β-CD is popular by its brand name Captisol®. The present review discusses the structure, properties, and preparation methods of SBE-β-CD-based inclusion complexes (ICs). Furthermore, we discuss here the preparation and applications of SBE-β-CD ICs-based nanoparticulate drug delivery systems, which combines the merits of both, ICs (enhanced solubility) and nanoparticles (NPs, targeted therapy). Patents on and FDA-approved Captisol®-enabled products are tabulated in the benefit of readers. The toxicological aspects and current clinical status of SBE-β-CD or SBE-β-CD-based products are briefly explained in the present review. In our opinion, the present review would be a pathfinder to allow dissemination of information on SBE-β-CD.
科研通智能强力驱动
Strongly Powered by AbleSci AI